Future directions in the treatment of osteosarcoma

MW Bishop, KA Janeway, R Gorlick - Current opinion in pediatrics, 2016 - journals.lww.com
Future directions in the treatment of osteosarcoma : Current Opinion in Pediatrics Future
directions in the treatment of osteosarcoma : Current Opinion in Pediatrics Log in or Register …

Cells of origin in osteosarcoma: mesenchymal stem cells or osteoblast committed cells?

AJ Mutsaers, CR Walkley - Bone, 2014 - Elsevier
Osteosarcoma is a disease with many complex genetic abnormalities but few well defined
genetic drivers of tumor initiation and evolution. The disease is diagnosed and defined …

[HTML][HTML] Modeling familial cancer with induced pluripotent stem cells

DF Lee, J Su, HS Kim, B Chang, D Papatsenko, R Zhao… - Cell, 2015 - cell.com
In vitro modeling of human disease has recently become feasible with induced pluripotent
stem cell (iPSC) technology. Here, we established patient-derived iPSCs from a Li-Fraumeni …

[HTML][HTML] Dysregulated m6A-related regulators are associated with tumor metastasis and poor prognosis in osteosarcoma

J Li, B Rao, J Yang, L Liu, M Huang, X Liu, G Cui… - Frontiers in …, 2020 - frontiersin.org
Background: Osteosarcoma (OS) is the most common primary bone tumor. The disease has
a poor prognosis due to the delay in the diagnosis and the development of metastasis. N6 …

Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma

CE Lietz, ET Newman, AD Kelly, DH Xiang… - Communications …, 2022 - nature.com
Aberrant methylation of genomic DNA has been reported in many cancers. Specific DNA
methylation patterns have been shown to provide clinically useful prognostic information …

MicroRNA function and dysregulation in bone tumors: the evidence to date

M Nugent - Cancer management and research, 2014 - Taylor & Francis
Micro ribonucleic acids (miRNAs) are small non-coding RNA segments that have a role in
the regulation of normal cellular development and proliferation including normal …

Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma

Y Chen, B Zhao, X Wang - BMC cancer, 2020 - Springer
Background Osteosarcoma is a rare malignant bone tumor in adolescents and children.
Poor prognosis has always been a difficult problem for patients with osteosarcoma. Recent …

Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death

S Bhattacharya, AM Chalk, AJM Ng, TJ Martin… - Oncogene, 2016 - nature.com
Osteosarcoma (OS) is the most common cancer of bone and the 5th leading cause of cancer-
related death in young adults. Currently, 5-year survival rates have plateaued at~ 70% for …

Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for …

J Yang, J Zhang, S Na, Z Wang, H Li, Y Su, L Ji… - Frontiers in …, 2022 - frontiersin.org
Background Despite the comparatively low prevalence of osteosarcoma (OS) compared to
other cancer types, metastatic OS has a poor overall survival rate of fewer than 30 …

Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling

H Fan, S Lu, S Wang, S Zhang - Molecular Medicine …, 2019 - spandidos-publications.com
Osteosarcoma is the most common type of malignant bone cancer, which often affects
teenagers and young adults. The present study aimed to screen for critical genes and …